Max Golden

Max Golden

Morrison Intern

Hometown: Madison, WI
Education: Yale University (New Haven, CT)
MD Mentor: Jason Alexander
Staff Mentor: Stephanie Ebnet
Projects: Treating Infrainguinal Arterial Disease in Patients with Below the Knee Amputations; Does an algorithm for the management of percutaneous femoral arterial access decrease the risk of surgical complications?

Max Golden comes by way of Madison, Wisconsin and is currently a senior with plans on graduating in May of 2020 from Yale University.  Max would like to pursue a career as a physician and is motivated by the daily intellectual challenges that a career in medicine presents.  Max also appreciates the evolving and expanding nature of medicine, and he is hopeful that one day “I have the opportunity to work in medicine and make sure that patients get the best possible care.”

Max was interested in participating in this research internship because of the unique opportunity to explore his interest in clinical research while having the ability to shadow established physicians in the clinical setting.  He is also looking forward to observing the life-cycle of a clinical research project and studying the medical device design process with visits to Boston Scientific and Medtronic.  Max hopes to separate himself from other pre-medical students by gaining early exposure to experiences typically reserved for medical school students.

Throughout the duration of this summer’s research internship, Max will be involved in two studies under the guidance of Dr. Jason Alexander and staff mentor Stephanie Ebnet.  The first study is: Does an Algorithm for the Management of Percutaneous Femoral Arterial Access Decrease the Risk of Surgical Complications?  The goal of this study is to establish whether a standard protocol for percutaneous femoral arterial access decreases the incidence of life-threatening bleeding or limb-threatening ischemia.  The second study is: Treating Infrainguinal Arterial Disease in Patients with Below the Knee Amputations, which pertains to determining whether patients with below-the-knee amputations and infrainguinal vascular disease can successfully undergo arterial intervention instead of further amputation above the knee- which could severely hinder their mobility.

As a summer research intern, Max has discovered that caring for a patient and conducting a clinical study can coexist.  After this summer Max has plans to finish his bachelor’s degree from Yale University, and during his gap year, he plans on either working on clinical research projects or working full-time as an Emergency Medical Technician.

 

Back to Meet the 2019 Interns

 Max Golden
Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.